OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease
Zoe R. Maylin, Radu CB Nicolescu, Hardev Pandha, et al.
Translational Oncology (2021) Vol. 14, Iss. 8, pp. 101115-101115
Open Access | Times Cited: 13
Zoe R. Maylin, Radu CB Nicolescu, Hardev Pandha, et al.
Translational Oncology (2021) Vol. 14, Iss. 8, pp. 101115-101115
Open Access | Times Cited: 13
Showing 13 citing articles:
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11088-11088
Open Access | Times Cited: 127
Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11088-11088
Open Access | Times Cited: 127
Nuclear receptors: from molecular mechanisms to therapeutics
Daniel E. Frigo, Maria Bondesson, Cecilia Williams
Essays in Biochemistry (2021) Vol. 65, Iss. 6, pp. 847-856
Open Access | Times Cited: 87
Daniel E. Frigo, Maria Bondesson, Cecilia Williams
Essays in Biochemistry (2021) Vol. 65, Iss. 6, pp. 847-856
Open Access | Times Cited: 87
Androgen receptor cofactors: A potential role in understanding prostate cancer
Xiang Li, Haojun Xiong, Xingzhu Mou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116338-116338
Open Access | Times Cited: 6
Xiang Li, Haojun Xiong, Xingzhu Mou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116338-116338
Open Access | Times Cited: 6
A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
Katie Joanna Miller, Isla Henry, Zoe R. Maylin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Katie Joanna Miller, Isla Henry, Zoe R. Maylin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Assessing novel analogues of nilutamide as a human androgen receptor antagonist: A detailed investigation of drug design using a bioisosteric methodology including ADMET profiling, molecular docking studies and molecular dynamics simulation
Ajay Gupta, Yogita Sahu, Dipti Pal, et al.
Computational Biology and Chemistry (2025), pp. 108424-108424
Closed Access
Ajay Gupta, Yogita Sahu, Dipti Pal, et al.
Computational Biology and Chemistry (2025), pp. 108424-108424
Closed Access
Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021)
Youquan Xie, Yucheng Tian, Yuming Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114119-114119
Closed Access | Times Cited: 18
Youquan Xie, Yucheng Tian, Yuming Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114119-114119
Closed Access | Times Cited: 18
Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies
N.P. THAKUR, Pallavi Singh, Aditi Bagri, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1110-1134
Open Access | Times Cited: 3
N.P. THAKUR, Pallavi Singh, Aditi Bagri, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1110-1134
Open Access | Times Cited: 3
Androgen receptor, PARP signaling, and tumor microenvironment: the ‘perfect triad’ in prostate cancer?
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer
Katie Joanna Miller, Mohammad Asim
Cells (2022) Vol. 11, Iss. 6, pp. 952-952
Open Access | Times Cited: 8
Katie Joanna Miller, Mohammad Asim
Cells (2022) Vol. 11, Iss. 6, pp. 952-952
Open Access | Times Cited: 8
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities
Claudia Piombino, Stefania Pipitone, Elena Tonni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4624-4624
Open Access | Times Cited: 1
Claudia Piombino, Stefania Pipitone, Elena Tonni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4624-4624
Open Access | Times Cited: 1
N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review
Ye Chen, Tian Lan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Ye Chen, Tian Lan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance
Radu Costin Bizga Nicolescu, Zoe R. Maylin, F. Javier Pérez-Areales, et al.
ChemMedChem (2022) Vol. 18, Iss. 2
Open Access | Times Cited: 4
Radu Costin Bizga Nicolescu, Zoe R. Maylin, F. Javier Pérez-Areales, et al.
ChemMedChem (2022) Vol. 18, Iss. 2
Open Access | Times Cited: 4
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer
Zoe R. Maylin, Christopher D. Smith, Adam Classen, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1999-1999
Open Access
Zoe R. Maylin, Christopher D. Smith, Adam Classen, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1999-1999
Open Access
